APA (7th ed.) Citation

Freedland, S. J., & Shore, N. (2026). Reply to Xianghu Meng, Yibo Hua, and Rijin Song's Letter to the Editor re: Stephen J. Freedland, John P. Mulhall, Martin Gleave, et al. Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study. Eur Urol 2025;87:507–11. European Urology, 89(4), e94. https://doi.org/10.1016/j.eururo.2025.09.4179

Chicago Style (17th ed.) Citation

Freedland, Stephen J., and Neal Shore. "Reply to Xianghu Meng, Yibo Hua, and Rijin Song's Letter to the Editor Re: Stephen J. Freedland, John P. Mulhall, Martin Gleave, Et Al. Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study. Eur Urol 2025;87:507–11." European Urology 89, no. 4 (2026): e94. https://doi.org/10.1016/j.eururo.2025.09.4179.

MLA (9th ed.) Citation

Freedland, Stephen J., and Neal Shore. "Reply to Xianghu Meng, Yibo Hua, and Rijin Song's Letter to the Editor Re: Stephen J. Freedland, John P. Mulhall, Martin Gleave, Et Al. Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study. Eur Urol 2025;87:507–11." European Urology, vol. 89, no. 4, 2026, p. e94, https://doi.org/10.1016/j.eururo.2025.09.4179.